Cat. No. |
Product Name |
Information |
PC-21600 |
BMS-582949
p38 MAPK inhibitor
|
BMS-582949 is a potent, selective and orally active p38α MAP kinase inhibitor with IC50 of 13 nM, exhibits significant inhibition of TNFα release in hPBMC with IC50 of 50 nM. |
PC-21599 |
Dilmapimod
p38 MAPK inhibitor
|
SB-681323 is a potent and selective p38 MAPK inhibitor, potentially suppresses inflammation in chronic obstructive pulmonary disease. |
PC-20954 |
NC-p38i NC-37
p38α inhibitor
|
Non-canonical p38α inhibitor NC-37 (NC-p38i NC-37) is a potent, highly selective, non-canonical inhibitor of p38α, inhibits TAB1-induced p38α autophosphorylation in vitro with IC50 of 0.27 uM. |
PC-20953 |
NC-p38i NC-38
p38α inhibitor
|
Non-canonical p38α inhibitor NC-38 (NC-p38i NC-38) is a potent, highly selective, non-canonical inhibitor of p38α, inhibits TAB1-induced p38α autophosphorylation in vitro with IC50 of 0.27 uM. |
PC-49694 |
VCP979
p38 MAPK inhibitor
|
VCP979 (VCP-979) is a novel selective small molecule p38 MAPK inhibitor with a significantly greater affinity for the active form of p38 MAPK, has significant anti-fibrotic effects in vitro and in vivo. |
PC-42492 |
SB 203580 hydrochloride
|
A specific p38 MAPK inhibitor with IC50 of 0.6 uM. |